Tokyo, Japan

Masao Hoshiyama


Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 35(Granted Patents)


Location History:

  • Tokyo, JA (1976 - 1978)
  • Tokyo, JP (1978)

Company Filing History:


Years Active: 1976-1978

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Masao Hoshiyama: Innovator in Pharmaceutical Chemistry

Introduction

Masao Hoshiyama is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 4 patents to his name, Hoshiyama's work focuses on anti-diabetic and cardiotonic agents.

Latest Patents

Hoshiyama's latest patents include innovative benzylalcohol derivatives and processes for their preparation. One of his notable inventions is a compound that can be synthesized by reducing a specific precursor compound. This compound, along with its pharmaceutically acceptable acid addition salt, has shown potential as an anti-diabetic agent. Another significant patent involves a compound that is prepared through catalytic hydrogenation, which is useful as a cardiotonic agent. The versatility of these compounds highlights Hoshiyama's expertise in creating effective pharmaceutical solutions.

Career Highlights

Masao Hoshiyama is currently associated with Tanabe Seiyaku Company, Limited, where he continues to advance his research in pharmaceutical innovations. His work has not only contributed to the scientific community but has also paved the way for new treatments in the medical field.

Collaborations

Hoshiyama has collaborated with notable colleagues, including Muneyoshi Ikezaki and Nobuo Ito. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Masao Hoshiyama's contributions to pharmaceutical chemistry are noteworthy, with a focus on developing innovative compounds for medical use. His patents reflect a commitment to advancing healthcare through scientific innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…